Dataciencia

Colección SciELO Chile

Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: An open-label study Glaucoma

Indexado

WoS	WOS:000364541900001
Scopus	SCOPUS_ID:84946918323

DOI

10.1186/S12886-015-0151-7

Año

2015

Tipo

artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras

Abstract

Conclusions: Transitioning from BAK-containing latanoprost 0.005 % to BAK-free travoprost 0.004 % preserved with PQ reduced IOP in patients with open-angle glaucoma or ocular hypertension who were intolerant of latanoprost. BAK-free travoprost 0.004 % is a viable alternative for patients who require switching their IOP-lowering medications because of tolerability issues.

Revista

Revista	ISSN
Bmc Ophthalmology	1471-2415

Métricas Externas

PlumX	Altmetric	Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Plumx: https://plumanalytics.com/learn/about-metrics/
Altmetric: https://www.altmetric.com/about-altmetrics/what-are-altmetrics/
Dimensions: https://www.dimensions.ai/why-dimensions/

Disciplinas de Investigación

WOS
Ophthalmology

Scopus
Sin Disciplinas

SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional

Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.

Autores - Afiliación

Ord.	Autor	Género	Institución - País
1	Lopes, Joao F.	-	Clin Oftalmol Pasteur - Chile Clínica Oftalmológica Pasteur - Chile
2	Hubatsch, Douglas A.	Hombre	Alcon Labs Inc - Estados Unidos Alcon Laboratories, Inc. - Estados Unidos
3	Amaris, Patricia	Mujer	Clin Oftalmol Caribe - Colombia Clínica Oftalmológica del Caribe, Barranquilla - Colombia

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento

Fuente
Alcon
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. (Fort Worth, TX)

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos

Agradecimiento
This study was funded by Alcon Laboratories, Inc. (Fort Worth, TX). The study sponsor participated in study design and data collection, analysis, and interpretation, and supported the decision to submit this manuscript for publication. Medical writing support was provided by Anny Wu, PharmD, and Jillian Gee, PhD, CMPP, of Complete Healthcare Communications, Inc. (Chadds Ford, PA) and was funded by Alcon.
This study was funded by Alcon Laboratories, Inc. (Fort Worth, TX). The study sponsor participated in study design and data collection, analysis, and interpretation, and supported the decision to submit this manuscript for publication. Medical writing support was provided by Anny Wu, PharmD, and Jillian Gee, PhD, CMPP, of Complete Healthcare Communications, Inc. (Chadds Ford, PA) and was funded by Alcon.

Agradecimiento

This study was funded by Alcon Laboratories, Inc. (Fort Worth, TX). The study sponsor participated in study design and data collection, analysis, and interpretation, and supported the decision to submit this manuscript for publication. Medical writing support was provided by Anny Wu, PharmD, and Jillian Gee, PhD, CMPP, of Complete Healthcare Communications, Inc. (Chadds Ford, PA) and was funded by Alcon.